Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain

Ivan Ivanov, Anton Matafonov, Mao-fu Sun, Bassem M. Mohammed, Qiufang Cheng, S. Kent Dickeson, Suman Kundu, Ingrid M. Verhamme, Andras Gruber, Keith McCrae, David Gailani

Blood (2019) 133 (10): 1152–1163.

https://doi.org/10.1182/blood-2018-06-860270

Published: 2019

Includes: Supplemental data

Journal Articles

A Novel Immunoblot Assay to Detect Contact Activation in Patients with Cancer

Dewen You, PhD, Victor Chatterjee, MD, Mohamed Samour, MBBS, Suman Kundu, MBA, Alvin H. Schmaier, MD, Alok A. Khorana, MD, Keith McCrae, MD

Blood (2017) 130 (Supplement 1): 2385.

https://doi.org/10.1182/blood.V130.Suppl_1.2385.2385

Published: 2017

Journal Articles

High Molecular Weight Kininogen Alters the Tumor Microenvironment and Reduces Tumor Stem Cell Content

Meenal Shukla, James Hale, PhD, Justin Lathia, PhD, Keith McCrae, MD

Blood (2017) 130 (Supplement 1): 2340.

https://doi.org/10.1182/blood.V130.Suppl_1.2340.2340

Published: 2017

Journal Articles

Cancer Cell-Derived Extracellular Vesicles Are Prothrombotic in an in-Vitro Vessel Model

Victor Chatterjee, MD, Mohamed Samour, MBBS, Dewen You, PhD, Suman Kundu, MBA, Alok A. Khorana, MD, Keith McCrae, MD

Blood (2017) 130 (Supplement 1): 2308.

https://doi.org/10.1182/blood.V130.Suppl_1.2308.2308

Published: 2017

Journal Articles

Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results

James B. Bussel, MD, Donald M Arnold, MD, Nichola Cooper, MA, MD MRCP, FRCPath, Alhossain A Khalafallah, MD, Michael Boxer, MD, Darla Liles, MD, Waleed Ghanima, MD PhD, Keith McCrae, MD, Hany Zayed, Benoit Cadieux, PhD, Anne-Marie Duliege, MDMS

Blood (2017) 130 (Supplement 1): 16.

https://doi.org/10.1182/blood.V130.Suppl_1.16.16

Published: 2017

Journal Articles

Factors Associated with Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Results from the United States Thrombotic Microangiopathy TTP Registry

Todd Clover, MD MS, Ronald S. Go, MD, Ana G. Antun, MD, Spero R Cataland, MD, Shruti Chaturvedi, MBBS,MS, Elizabeth Davis, Andrew Johnson, MD, Ming Yeong Lim, MBBChir, Meera Sridharan, MD, Keith McCrae, MD, J. Evan Sadler, MD PhD, Marshall A. Mazepa, MD, Lisa Baumann-Kreuziger, MS MD

Blood (2017) 130 (Supplement 1): 3624.

https://doi.org/10.1182/blood.V130.Suppl_1.3624.3624

Published: 2017

Journal Articles

The Impact of Detectable ADAMTS13 Inhibitor on the Clinical Presentation and Outcome of Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Analysis Using the United States Thrombotic Microangiopathy (USTMA) Clinical Registry

Meera Sridharan, MD, Ana G Antun, MD, Lisa Baumann Kreuziger, Assistant Professor. MD MS, Spero R Cataland, MD, Shruti Chaturvedi, MBBS,MS, Todd Clover, MD, Elizabeth Davis, Andrew Johnson, MD, Keith McCrae, MD, Ming Yeong Lim, MBBChir, J. Evan Sadler, MD PhD, Marshall A. Mazepa, MD, Ronald S Go, MD

Blood (2017) 130 (Supplement 1): 3620.

https://doi.org/10.1182/blood.V130.Suppl_1.3620.3620

Published: 2017

Journal Articles

Comparison of FXII Activation in Human Plasma By Extracellular Vesicles from Cancer Cells Versus Non-Transformed Cells

Dewen You, PhD, Victor Chatterjee, MD, Suman Kundu, MBA, Mohamed Samour, MBBS, Alvin H. Schmaier, MD, Alok A. Khorana, MD, Keith McCrae, MD

Blood (2017) 130 (Supplement 1): 3705.

https://doi.org/10.1182/blood.V130.Suppl_1.3705.3705

Published: 2017

Journal Articles

VTE Recurrence and Safety of Anticoagulants Among Patients with Cancer Treated for Venous Thromboembolism

Alok A. Khorana, MD, Keith McCrae, MD, Dejan Milentijevic, Nora McCormick, François Laliberté, Concetta Crivera, Patrick Lefebvre, MA, Dominique Lejeune, Heather Rozjabek, Jeff Schein, Michael B. Streiff

Blood (2017) 130 (Supplement 1): 4631.

https://doi.org/10.1182/blood.V130.Suppl_1.4631.4631

Published: 2017

Journal Articles

Treatment of Cancer Associated Venous Thrombosis; The Cleveland Clinic Experience

Shafia Rahman, Dana E. Angelini, MD, Paul Elson, PhD, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barb Tripp, CNS,AOCN, Jung- Min Song, RN,CNS, Keith McCrae, MD, Alok A. Khorana, MD

Blood (2017) 130 (Supplement 1): 4633.

https://doi.org/10.1182/blood.V130.Suppl_1.4633.4633

Published: 2017

Journal Articles

Healthcare Costs Associated with Venous Thromboembolism in Cancer Patients Treated with Anticoagulants

Michael B. Streiff, Keith McCrae, MD, Dejan Milentijevic, Nora McCormick, François Laliberté, Concetta Crivera, Patrick Lefebvre, MA, Dominique Lejeune, Heather Rozjabek, Jeff Schein, Alok A. Khorana, MD

Blood (2017) 130 (Supplement 1): 4640.

https://doi.org/10.1182/blood.V130.Suppl_1.4640.4640

Published: 2017

Journal Articles

Anticoagulant Prescription Patterns for Cancer Associated Thrombosis: New Insights into the Use of Direct Oral Anticoagulants

Dana E. Angelini, MD, Paul Elson, PhD, Keith McCrae, MD, Alok A. Khorana, MD

Blood (2017) 130 (Supplement 1): 4725.

https://doi.org/10.1182/blood.V130.Suppl_1.4725.4725

Published: 2017

Journal Articles

RNA Sequencing Approaches to Identify Novel Biomarkers for Venous Thromboembolism (VTE) in Lung Cancer

Tamara A. Sussman, MD, Mohamed Abazeed, MD PhD, Keith McCrae, MD, Alok A. Khorana, MD

Blood (2017) 130 (Supplement 1): 554.

https://doi.org/10.1182/blood.V130.Suppl_1.554.554

Published: 2017

Journal Articles

Implementation of an Electronic Medical Record Tool for Early Detection of Deep Vein Thrombosis in the Ambulatory Oncology Setting: The Cleveland Clinic Experience

Girish Kunapareddy, MD, Benjamin Switzer, DO, MHSA, MS, Madison Conces, MD, Pramod Pinnamaneni, MD, Bhumika J. Patel, MD, Sagar S. Patel, MD, Alicia Redden, Dana E. Angelini, MD, Keith McCrae, MD, Brad Pohlman, MD, Alok A. Khorana, MD

Blood (2017) 130 (Supplement 1): 3361.

https://doi.org/10.1182/blood.V130.Suppl_1.3361.3361

Published: 2017

Journal Articles

A Descriptive Analysis of the Demographics and Presenting Symptoms of Patients in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry

Elizabeth Davis, Ana G. Antun, MD, Lisa Baumann Kreuziger, MD MS, J. Evan Sadler, MD PhD, Spero R Cataland, MD, Meera Sridharan, MD, Todd Clover, MD, Andrew Johnson, MD, Keith McCrae, MD, Shruti Chaturvedi, MBBS,MS, Ronald S. Go, MD, Ming Yeong Lim, MBBChir, Marshall A. Mazepa, MD

Blood (2017) 130 (Supplement 1): 1049.

https://doi.org/10.1182/blood.V130.Suppl_1.1049.1049

Published: 2017

Journal Articles

Safety of Anticoagulant Therapies for Treatment of Venous Thromboembolism in Patients with Cancer

Michael Streiff, MD, Dejan Milentijevic, Keith McCrae, Daniel Yannicelli, Jonathan Fortier, Winnie Nelson, François Laliberté, MA, Concetta Crivera, PharmD, MPH, Patrick Lefebvre, MA, Jeff Schein, DrPH, MPH, Alok A. Khorana, MD

Blood (2016) 128 (22): 1178.

https://doi.org/10.1182/blood.V128.22.1178.1178

Published: 2016

Journal Articles

Current Practice Patterns and Patient Persistence on Anticoagulant Treatments for Cancer-Associated Thrombosis

Alok A. Khorana, MD, Keith McCrae, Dejan Milentijevic, Jonathan Fortier, Winnie Nelson, François Laliberté, Concetta Crivera, Patrick Lefebvre, Daniel Yannicelli, Jeff Schein

Blood (2015) 126 (23): 626.

https://doi.org/10.1182/blood.V126.23.626.626

Published: 2015

Journal Articles

Impact of a Cancer Associated Thrombosis Clinic on Reducing Hospitalization for Venous Thromboembolism: The Cleveland Clinic Experience

Amber Afzal, MD, Alok A. Khorana, MD, Moshe Ornstein, MD MA, Keith McCrae

Blood (2015) 126 (23): 5588.

https://doi.org/10.1182/blood.V126.23.5588.5588

Published: 2015

Journal Articles

Endothelial Derived Microparticles Bind and Activate Platelets in a CD36 Dependent Manner.

Arunima Ghosh, MD, Maria Febbraio, PhD, Keith McCrae, MD, Roy L. Silverstein, MD

Blood (2007) 110 (11): 418.

https://doi.org/10.1182/blood.V110.11.418.418

Published: 2007

Journal Articles

β 2 -Glycoprotein I Is a Cofactor for t-PA-Mediated Plasminogen Activation.

Chunya Bu, PhD, Lei Gao, PhD, Weidong Xie, Jianwei Zhang, MD, PhD, Yuhong He, Guoping Cai, PhD, Keith McCrae, MD

Blood (2007) 110 (11): 404.

https://doi.org/10.1182/blood.V110.11.404.404

Published: 2007

NARROW

A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain

A Novel Immunoblot Assay to Detect Contact Activation in Patients with Cancer

High Molecular Weight Kininogen Alters the Tumor Microenvironment and Reduces Tumor Stem Cell Content

Cancer Cell-Derived Extracellular Vesicles Are Prothrombotic in an in-Vitro Vessel Model

Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results

Factors Associated with Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Results from the United States Thrombotic Microangiopathy TTP Registry

The Impact of Detectable ADAMTS13 Inhibitor on the Clinical Presentation and Outcome of Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP): Analysis Using the United States Thrombotic Microangiopathy (USTMA) Clinical Registry

Comparison of FXII Activation in Human Plasma By Extracellular Vesicles from Cancer Cells Versus Non-Transformed Cells

VTE Recurrence and Safety of Anticoagulants Among Patients with Cancer Treated for Venous Thromboembolism

Treatment of Cancer Associated Venous Thrombosis; The Cleveland Clinic Experience

Healthcare Costs Associated with Venous Thromboembolism in Cancer Patients Treated with Anticoagulants

Anticoagulant Prescription Patterns for Cancer Associated Thrombosis: New Insights into the Use of Direct Oral Anticoagulants

RNA Sequencing Approaches to Identify Novel Biomarkers for Venous Thromboembolism (VTE) in Lung Cancer

Implementation of an Electronic Medical Record Tool for Early Detection of Deep Vein Thrombosis in the Ambulatory Oncology Setting: The Cleveland Clinic Experience

A Descriptive Analysis of the Demographics and Presenting Symptoms of Patients in the U.S. Thrombotic Microangiopathy (USTMA) TTP Registry

Safety of Anticoagulant Therapies for Treatment of Venous Thromboembolism in Patients with Cancer

Current Practice Patterns and Patient Persistence on Anticoagulant Treatments for Cancer-Associated Thrombosis

Impact of a Cancer Associated Thrombosis Clinic on Reducing Hospitalization for Venous Thromboembolism: The Cleveland Clinic Experience

Endothelial Derived Microparticles Bind and Activate Platelets in a CD36 Dependent Manner.

β 2 -Glycoprotein I Is a Cofactor for t-PA-Mediated Plasminogen Activation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only